• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Insys Therapeutics Inc

+ Add to Watchlist

INSY:US

42.7200 USD 2.6200 5.78%

As of 14:34:01 ET on 12/22/2014.

Snapshot for Insys Therapeutics Inc (INSY)

Open: 45.2900 Day's Range: 41.8100 - 45.3400 Volume: 358,880
Previous Close: 45.3400 52wk Range: 20.5200 - 57.9133 1-Yr Rtn: +63.15%

Stock Chart for INSY

No chart data available.
  • INSY:US 42.7200
  • 1D
  • 1M
  • 1Y
45.3400
Interactive INSY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSY

Current P/E Ratio (ttm) 23.7095
Estimated P/E(12/2014) 24.9707
Relative P/E vs. SPX 1.2971
Earnings Per Share (USD) (ttm) 1.7900
Est. EPS (USD) (12/2014) 1.7080
Est. PEG Ratio 0.9792
Market Cap (M USD) 1,483.61
Shares Outstanding (M) 34.96
30 Day Average Volume 430,315
Price/Book (mrq) 10.2193
Price/Sale (ttm) 6.6449
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/04/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSY

Insys Therapeutics, Inc. develops cancer support drugs. The Company's support care candidates include a fast-acting sublingual spray for cancer pain, and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.

John N KapoorChairmanMichael L BabichPresident/CEO
Darryl S BakerChief Financial OfficerFranc E Del Fosse IIISecretary/General Counsel
More Company Profile & Key Executives for INSY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil